StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

Yarrow Bioscience's gross margin for the twelve months ending Dec 31, 2021 was -259.6%. For fiscal 2021 it was -259.6%, against 93.4% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021-259.6%−353.0
FY2020Dec 31, 202093.4%−6.6
FY2019Dec 31, 2019100.0%+0.0
FY2018Dec 31, 2018100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2021Dec 31, 2021-230.8%+249.8
Q3 FY2021Sep 30, 2021-688.7%−777.4
Q2 FY2021Jun 30, 2021-169.5%−267.6
Q1 FY2021Mar 31, 2021-161.3%−245.8
Q4 FY2020Dec 31, 2020-480.6%−580.6
Q3 FY2020Sep 30, 202088.7%+5245.8
Q2 FY2020Jun 30, 202098.2%–
Q1 FY2020Mar 31, 202084.5%–
Q4 FY2019Dec 31, 2019100.0%–
Q1 FY2019Mar 31, 2019-5157.1%–

More Yarrow Bioscience figures

See a number that looks wrong?